$EPZM Epizyme, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Epizyme, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Epizyme, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Epizyme, Inc. for free.

CIK Number: 0001571498
IRS Number: 261349956
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: EPZM
Company Address: 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE 02139

Epizyme, Inc. is a clinical-stage biopharmaceutical company, which engage in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. It also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA.

Market Capitalization: $707.73M
Prev close: $12.05
Average Daily Volume: 337,735
Days Low: $11.95
Year Low: $7.02
Year High: $13.46

Epizyme, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Agarwal ShefaliChief Medical Officer32,894396,373shares bought: 65,788 / shares sold: 0 STRONG BUYJan 28 20193 months ago
Bazemore Robert BPresident & CEO80,068964,819shares bought: 152,128 / shares sold: 0 STRONG BUYJan 28 20193 months ago
Beaulieu JosephCorporate Controller00Jan 28 20193 months ago
Ros MatthewChief Operating Officer36,217436,415shares bought: 139,760 / shares sold: -72,264 STRONG BUYJan 28 20193 months ago

View all Epizyme, Inc. insiders.

Epizyme, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 28 2019EPZMEpizyme, Inc.Ros MatthewChief Operating Off ...Option ExerciseA9.12151,6201,382,774151,620
Jan 28 2019EPZMEpizyme, Inc.Ros MatthewChief Operating Off ...GrantA0.0032,894036,2173.3 K to 36.2 K (+989.89 %)
Jan 28 2019EPZMEpizyme, Inc.Beaulieu JosephCorporate Controlle ...Option ExerciseA9.1224,523223,65024,523
Jan 28 2019EPZMEpizyme, Inc.Agarwal ShefaliChief Medical Offic ...Option ExerciseA9.12151,6201,382,774151,620
Jan 28 2019EPZMEpizyme, Inc.Agarwal ShefaliChief Medical Offic ...GrantA0.0032,894032,8940 to 32.9 K
Jan 28 2019EPZMEpizyme, Inc.Bazemore Robert BPresident & CEOOption ExerciseA9.12347,4643,168,872347,464
Jan 28 2019EPZMEpizyme, Inc.Bazemore Robert BPresident & CEOGrantA0.0075,383080,0684.7 K to 80.1 K (+1,609.03 %)
Jan 28 2019EPZMEpizyme, Inc.Ros MatthewChief Operating Off ...Option ExerciseA9.12151,6201,382,774151,620
Jan 28 2019EPZMEpizyme, Inc.Ros MatthewChief Operating Off ...GrantA0.0032,894036,2173.3 K to 36.2 K (+989.89 %)
Jan 28 2019EPZMEpizyme, Inc.Beaulieu JosephCorporate Controlle ...Option ExerciseA9.1224,523223,65024,523
Jan 28 2019EPZMEpizyme, Inc.Agarwal ShefaliChief Medical Offic ...Option ExerciseA9.12151,6201,382,774151,620
Jan 28 2019EPZMEpizyme, Inc.Agarwal ShefaliChief Medical Offic ...GrantA0.0032,894032,8940 to 32.9 K
Jan 28 2019EPZMEpizyme, Inc.Bazemore Robert BPresident & CEOOption ExerciseA9.12347,4643,168,872347,464
Jan 28 2019EPZMEpizyme, Inc.Bazemore Robert BPresident & CEOGrantA0.0075,383080,0684.7 K to 80.1 K (+1,609.03 %)
Oct 05 2018EPZMEpizyme, Inc.MOTT DAVID MDirectorBuyP9.00416,6673,750,0036,471,0186.1 M to 6.5 M (+6.88 %)

View all Epizyme, Inc. insider transactions.